Bioethics of intervention and the case of drugs Bevacizumab and Ranibizumab for retinal diseases

From the year 2000, on a class of biological drugs, the anti-VEGF proved to be quite effective in the treatment of retinal diseases, which have in its pathophysiological mechanism an important vascular proliferation component that can lead to blindness. Two of these drugs, bevacizumab and ranibizuma...

詳細記述

書誌詳細
出版年:Revista Iberoamericana de Bioética
第一著者: Flávio R. L. Paranhos
フォーマット: 論文
言語:英語
出版事項: Universidad Pontificia Comillas 2016-10-01
主題:
オンライン・アクセス:http://revistas.upcomillas.es/index.php/bioetica-revista-iberoamericana/article/view/7346

類似資料